{"count": 8, "results": [{"_id": "33915173", "pmid": 33915173, "title": "TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.", "journal": "Gastroenterology", "authors": ["Eyres M", "Lanfredini S", "Xu H", "Burns A", "Blake A", "Willenbrock F", "Goldin R", "Hughes D", "Hughes S", "Thapa A", "Vavoulis D", "Hubert A", "D'Costa Z", "Sabbagh A", "Abraham AG", "Blancher C", "Jones S", "Verrill C", "Silva M", "Soonawalla Z", "Maughan T", "Schuh A", "Mukherjee S", "O'Neill E"], "date": "2021-08-01T00:00:00Z", "doi": "10.1053/j.gastro.2021.04.044", "meta_date_publication": "2021 Aug", "meta_volume": "161", "meta_issue": "2", "meta_pages": "653-668.e16", "score": 50237.477, "text_hl": "Importantly, enhancing @GENE_TET2 @GENE_54790 @@@TET2@@@ stability using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Ascorbic_Acid @CHEMICAL_MESH:D001205 @@@vitamin C@@@/@CHEMICAL_Ascorbic_Acid @CHEMICAL_MESH:D001205 @@@ascorbic acid@@@ restores @CHEMICAL_5_hydroxymethylcytosine @CHEMICAL_MESH:C011865 @@@5hmc@@@ and @GENE_GATA6 @GENE_2627 @@@GATA6@@@ levels, reverting @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@squamous-like tumor@@@ phenotypes and WNT-dependence in vitro and in vivo. ", "citations": {"NLM": "Eyres M, Lanfredini S, Xu H, Burns A, Blake A, Willenbrock F, Goldin R, Hughes D, Hughes S, Thapa A, Vavoulis D, Hubert A, D'Costa Z, Sabbagh A, Abraham AG, Blancher C, Jones S, Verrill C, Silva M, Soonawalla Z, Maughan T, Schuh A, Mukherjee S, O'Neill E. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes. Gastroenterology. 2021 Aug;161(2):653-668.e16. PMID: 33915173", "BibTeX": "@article{33915173, title={TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.}, author={Eyres M and Lanfredini S and Xu H and Burns A and Blake A and Willenbrock F and Goldin R and Hughes D and Hughes S and Thapa A and Vavoulis D and Hubert A and D'Costa Z and Sabbagh A and Abraham AG and Blancher C and Jones S and Verrill C and Silva M and Soonawalla Z and Maughan T and Schuh A and Mukherjee S and O'Neill E}, journal={Gastroenterology}, volume={161}, number={2}, pages={653-668.e16}}"}}, {"_id": "31014173", "pmid": 31014173, "title": "Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.", "journal": "Cell Cycle", "authors": ["Zhang Z", "Liang X", "Fan Y", "Gao Z", "Bindoff LA", "Costea DE", "Li L"], "date": "2019-05-01T00:00:00Z", "doi": "10.1080/15384101.2019.1598727", "meta_date_publication": "2019 May", "meta_volume": "18", "meta_issue": "9", "meta_pages": "949-962", "score": 50061.97, "text_hl": "Fibroblasts rescue @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@oral squamous cancer@@@ cell from @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced apoptosis via alleviating metabolic disbalance and inhibiting @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ pathway.", "citations": {"NLM": "Zhang Z, Liang X, Fan Y, Gao Z, Bindoff LA, Costea DE, Li L. Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway. Cell Cycle. 2019 May;18(9):949-962. PMID: 31014173", "BibTeX": "@article{31014173, title={Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.}, author={Zhang Z and Liang X and Fan Y and Gao Z and Bindoff LA and Costea DE and Li L}, journal={Cell Cycle}, volume={18}, number={9}, pages={949-962}}"}}, {"_id": "26904687", "pmid": 26904687, "pmcid": "PMC4745302", "title": "Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions", "journal": "Biomed Res Int", "authors": ["Yu H", "Bian X", "Gu D", "He X"], "date": "2016-01-01T00:00:00Z", "doi": "10.1155/2016/8678634", "meta_date_publication": "2016", "meta_volume": "2016", "meta_issue": "", "meta_pages": "8678634", "score": 50060.684, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Synergistically Enhances @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@Cisplatin@@@-Induced @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@Cytotoxicity@@@ in @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@Esophageal Squamous Cancer@@@ Cells under @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@Glucose@@@-Deprivation Conditions", "citations": {"NLM": "Yu H, Bian X, Gu D, He X. Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions Biomed Res Int. 2016;2016():8678634. PMID: 26904687", "BibTeX": "@article{26904687, title={Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions}, author={Yu H and Bian X and Gu D and He X}, journal={Biomed Res Int}, volume={2016}, pages={8678634}}"}}, {"_id": "28977926", "pmid": 28977926, "pmcid": "PMC5617486", "title": "Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin", "journal": "Oncotarget", "authors": ["Li PD", "Liu Z", "Cheng TT", "Luo WG", "Yao J", "Chen J", "Zou ZW", "Chen LL", "Ma C", "Dai XF"], "date": "2017-07-01T00:00:00Z", "doi": "10.18632/oncotarget.18907", "meta_date_publication": "2017 Sep 22", "meta_volume": "8", "meta_issue": "37", "meta_pages": "62057-62068", "score": 50052.363, "text_hl": "In this study, we provided evidence that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibits proliferation and induces apoptosis of @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@esophageal squamous cancer@@@ cells. ", "citations": {"NLM": "Li PD, Liu Z, Cheng TT, Luo WG, Yao J, Chen J, Zou ZW, Chen LL, Ma C, Dai XF. Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin Oncotarget. 2017 Sep 22;8(37):62057-62068. PMID: 28977926", "BibTeX": "@article{28977926, title={Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin}, author={Li PD and Liu Z and Cheng TT and Luo WG and Yao J and Chen J and Zou ZW and Chen LL and Ma C and Dai XF}, journal={Oncotarget}, volume={8}, number={37}, pages={62057-62068}}"}}, {"_id": "29274360", "pmid": 29274360, "title": "Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo.", "journal": "Cancer Lett", "authors": ["Jivan R", "Peres J", "Damelin LH", "Wadee R", "Veale RB", "Prince S", "Mavri-Damelin D"], "date": "2018-03-28T00:00:00Z", "doi": "10.1016/j.canlet.2017.12.026", "meta_date_publication": "2018 Mar 28", "meta_volume": "417", "meta_issue": "", "meta_pages": "1-10", "score": 50051.02, "text_hl": "These findings show that @CHEMICAL_Disulfiram @CHEMICAL_MESH:D004221 @@@DSF@@@ and @CHEMICAL_Disulfiram @CHEMICAL_MESH:D004221 @@@DSF@@@/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ significantly impede @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@OSCC tumour@@@ growth in vivo and offer prospective alternative chemotherapy approaches for @DISEASE_Esophageal_Squamous_Cell_Carcinoma @DISEASE_MESH:D000077277 @@@OSCC@@@.", "citations": {"NLM": "Jivan R, Peres J, Damelin LH, Wadee R, Veale RB, Prince S, Mavri-Damelin D. Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo. Cancer Lett. 2018 Mar 28;417():1-10. PMID: 29274360", "BibTeX": "@article{29274360, title={Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo.}, author={Jivan R and Peres J and Damelin LH and Wadee R and Veale RB and Prince S and Mavri-Damelin D}, journal={Cancer Lett}, volume={417}, pages={1-10}}"}}, {"_id": "28927103", "pmid": 28927103, "pmcid": "PMC5587978", "title": "Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer", "journal": "Oncol Lett", "authors": ["Thompson MD", "Lubet RA", "Mccormick DL", "Clapper ML", "Bode AM", "Juliana MM", "Moeinpour F", "Grubbs CJ"], "date": "2017-09-01T00:00:00Z", "doi": "10.3892/ol.2017.6632", "meta_date_publication": "2017 Sep", "meta_volume": "14", "meta_issue": "3", "meta_pages": "3480-3486", "score": 50048.184, "text_hl": "...Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the @CHEMICAL_4_Nitroquinoline_1_oxide @CHEMICAL_MESH:D015112 @@@4-NQO@@@-induced model of @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@squamous cell cancer@@@ grade and type. ", "citations": {"NLM": "Thompson MD, Lubet RA, Mccormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ. Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer Oncol Lett. 2017 Sep;14(3):3480-3486. PMID: 28927103", "BibTeX": "@article{28927103, title={Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer}, author={Thompson MD and Lubet RA and Mccormick DL and Clapper ML and Bode AM and Juliana MM and Moeinpour F and Grubbs CJ}, journal={Oncol Lett}, volume={14}, number={3}, pages={3480-3486}}"}}, {"_id": "24138903", "pmid": 24138903, "title": "Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.", "journal": "Lung Cancer", "authors": ["Ko JC", "Chiu HC", "Wo TY", "Huang YJ", "Tseng SC", "Huang YC", "Chen HJ", "Syu JJ", "Chen CY", "Jian YT", "Jian YJ", "Lin YW"], "date": "2013-12-01T00:00:00Z", "doi": "10.1016/j.lungcan.2013.09.011", "meta_date_publication": "2013 Dec", "meta_volume": "82", "meta_issue": "3", "meta_pages": "397-406", "score": 50047.336, "text_hl": "Inhibition of p38 MAPK-dependent @GENE_MSH2 @GENE_4436 @@@MutS homologue-2@@@ (@GENE_MSH2 @GENE_4436 @@@MSH2@@@) expression by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ enhances @CHEMICAL_Gefitinib @CHEMICAL_MESH:D000077156 @@@gefitinib@@@-induced @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@squamous lung cancer@@@ cells.", "citations": {"NLM": "Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, Lin YW. Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells. Lung Cancer. 2013 Dec;82(3):397-406. PMID: 24138903", "BibTeX": "@article{24138903, title={Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.}, author={Ko JC and Chiu HC and Wo TY and Huang YJ and Tseng SC and Huang YC and Chen HJ and Syu JJ and Chen CY and Jian YT and Jian YJ and Lin YW}, journal={Lung Cancer}, volume={82}, number={3}, pages={397-406}}"}}, {"_id": "29337896", "pmid": 29337896, "pmcid": "PMC5796212", "title": "Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-beta1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets", "journal": "Int J Mol Sci", "authors": ["Tyszka-Czochara M", "Lasota M", "Majka M"], "date": "2018-01-16T00:00:00Z", "doi": "10.3390/ijms19010266", "meta_date_publication": "2018 Jan 16", "meta_volume": "19", "meta_issue": "1", "meta_pages": "", "score": 50046.184, "text_hl": "The aim of this study was to evaluate the influence of natural compound @CHEMICAL_caffeic_acid @CHEMICAL_MESH:C040048 @@@Caffeic Acid@@@ (@CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@CA@@@) alone and in combination with antidiabetic drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@) on metastatic progression of two @SPECIES_9606 @@@human@@@ @<m>DISEASE_Neoplasms_Squamous_Cell</m> @DISEASE_MESH:D018307 @@@cervical squamous cell cancer@@@ lines, @CELLLINE_CVCL:2253 @@@C-4I@@@ and @CELLLINE_CVCL:A8FQ @@@HTB-35/SiHa@@@ cells. ", "citations": {"NLM": "Tyszka-Czochara M, Lasota M, Majka M. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-beta1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets Int J Mol Sci. 2018 Jan 16;19(1):. PMID: 29337896", "BibTeX": "@article{29337896, title={Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-beta1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets}, author={Tyszka-Czochara M and Lasota M and Majka M}, journal={Int J Mol Sci}, volume={19}, number={1}}"}}]}